Martin Auster, Chief Financial Officer at Ventyx Biosciences, Inc. (VTYX), sold 7,000 shares at $33.00 ($231K) on 2023-04-17, disclosed to the SEC on 2023-04-19.
Open-market sale of $231k VTYX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VTYX | SELL | 2023-07-26 | $995K | — | Filing → |
| VTYX | SELL | 2023-06-07 | $1.9M | — | Filing → |
| VTYX | SELL | 2023-04-27 | $2.1M | — | Filing → |